Institute of Genomics & Integrative Biology (IGIB) is a premier Institute of Council of Scientific and Industrial Research (CSIR), engaged in research of national importance in the areas of genomics, molecular medicine, bioinformatics, proteomics and environmental biotechnology.

read more

The University Institute of Pharmaceutical Sciences of the Panjab University is a premier institution of Pharmaceutical Education and Research in the country. The institute has covered a long and glorious journey of 76 years starting from Lahore in 1944 and finally settling to the present campus in Chandigarh at the foothills of Himachal. In its travelogue, the institute crossed multiple milestones and continue to head ahead towards the well-defined goals.

read more

Indian Institute of Chemical Technology, Hyderabad is a premier R&D Institute in India. The Institute had its origin as the Central Laboratories for Scientific & Industrial Research (CLSIR), established in 1944 by the then Government of Hyderabad State. After integration of Hyderabad State with the Indian Union, the laboratory expanded with its growing activities. The main building was formally opened by Pandit Jawaharlal Nehru, the then Prime Minister of India on January 2, 1954. In 1956, the Central Laboratories came under the aegis of the Council of Scientific & Industrial Research (CSIR), New Delhi and was renamed Regional Research Laboratory, Hyderabad (RRL-H).

read more

The National Institute of Pharmaceutical Education and Research (NIPER) at S.A.S. Nagar (Mohali) was created as a centre of excellence in imparting higher education, research and development in pharmaceutical sciences and is the first Institute of its kind in the country. The Institute was declared as an Institute of National Importance by the Government of India through an Act of Parliament, notified on 26th June 1998. During the years 2007 and 2008, Govt. of India established six more NIPERs at the following locations with the help of mentor institutes.

read more

GE Healthcare, $17 billion unit of General Electric Company (NYSE: GE), employing more than 46,000 people worldwide and serving healthcare professionals in more than 100 countries. We believe in our strategy - and we'd like you to be a part of it. As a global leader, GE can bring together the best in science, technology, business and people to help solve one of the world's toughest challenges and shape a new age of healthcare.

Post: Sales Specialist

read more

ABOUT AUTHORS:
Shalu Shukla
M.Pharmacy
Bahra University
shukla5828@gmail.com

ABSTRACT
The use of nanotechnology in medicine and more specifically drug delivery is set to spread rapidly. Currently many substances are under investigation for drug delivery and more specifically for cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient. The kind of hazards that are introduced by using nanoparticles for drug delivery are beyond that posed by conventional hazards imposed by chemicals in classical delivery matrices. For nanoparticles the knowledge on particle toxicity as obtained in inhalation toxicity shows the way how to investigate the potential hazards of nanoparticles. The toxicology of particulate matter differs from toxicology of substances as the composing chemical(s) may or may not be soluble in biological matrices, thus influencing greatly the potential exposure of various internal organs. This may vary from a rather high local exposure in the lungs and a low or neglectable exposure for other organ systems after inhalation. However, absorbed species may also influence the potential toxicity of the inhaled particles. For nanoparticles the situation is different as their size opens the potential for crossing the various biological barriers within the body. From a positive viewpoint, especially the potential to cross the blood brain barrier may open new ways for drug delivery into the brain. In addition, the nanosize also allows for access into the cell and various cellular compartments including the nucleus. A multitude of substances are currently under investigation for the preparation of nanoparticles for drug delivery, varying from biological substances like albumin, gelatin and phospholipids for liposomes, and more substances of a chemical nature like various polymers and solid metal containing nanoparticles. It is obvious that the potential interaction with tissues and cells, and the potential toxicity, greatly depends on the actual composition of the nanoparticle formulation. This paper provides an overview on some of the currently used systems for drug delivery.

read more

ABOUT AUTHORS:
*Anyonyya Mallam, surendar Angothu
Department of Pharmacognosy,
Vathsalya College of Pharmacy, Bhongir,
Nalgonda (Dist), Andhra Pradesh –  508116, India
*anyonyya1688@gmail.com

ABSTARCT
Infectious diseases are disorders caused by pathogenic microorganisms like bacteria, viruses, fungi, protozoa and multicellular parasites. The important cause of morbidity and mortality in developing countries is due to pathogenic microorganisms. Symptoms associated with bacterial infections such as headache, nausea, vomiting, fever, cough, cold and organ failures. The therapeutic use of medicinal plant is becoming popular because of their lesser side effects and low resistance in microorganisms.This article describes the antibacterial properties of  Oroxylum indicumVent., Lantana camara, Ruta graveolens, Argyreia  argentea, Mallotus  philippensis [Lam.] Muell. Arg. Var. philippensis, Mahonia manipurensis Takeda, Polyalthia longifoliavar. angustifolia, Prosopis cineraria (Linn.) druce, Bryonopsis laciniosa, Jatropha curcas.

read more

Bioinformatics Institute of India (BII), set-up in the year 2002 has acquired international reputation by conducting industry oriented knowledge enhancement programs in the emerging domains of life science. BII was established by the prestigious Confrere Educational Society. Within a short span of a decade, BII has traversed many milestones in academic excellence and is today recognized as premier institute for providing the training in the area of Bioinformatics, Biotechnology, Pharma, Clinical Trials etc. The course-curriculum has been designed on global industrial pattern to fill the gap between academia and industry has lead BII to attain professional expertise in the field of life science and its allied area.

BII is the largest Training Institute in Life Sciences Domain having more than 20,000 Satisfied Students over 25 countries. Since 2002 BII is thriving on:

• Laboratory Projects/Training
  
• Career enhancement Distance Learning Programs
  
• Programs from Jamia Hamdard University
  

<< CLICK TO JOIN >>

read more